148 related articles for article (PubMed ID: 33667585)
21. Real-world effectiveness and safety of stereotactic body radiotherapy for liver metastases with different respiratory motion management techniques.
Hernando-Requejo O; Chen X; López M; Sánchez E; García J; García P; Alonso R; Montero A; Ciervide R; Álvarez B; Zucca D; García Aranda M; Valero J; Fernández Letón P; Rubio C
Strahlenther Onkol; 2023 Nov; 199(11):1000-1010. PubMed ID: 37728734
[TBL] [Abstract][Full Text] [Related]
22. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Front Oncol; 2019; 9():1080. PubMed ID: 31681609
[No Abstract] [Full Text] [Related]
24. In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations.
Boda-Heggemann J; Jahnke A; Chan MKH; Ernst F; Ghaderi AL; Attenberger U; Hunold P; Schäfer JP; Wurster S; Rades D; Hildebrandt G; Lohr F; Dunst J; Wenz F; Blanck O
Radiother Oncol; 2019 May; 134():158-165. PubMed ID: 31005210
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
27. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
29. Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis.
Dreher C; Sarria GR; Miebach G; Weiss C; Buergy D; Wojtal P; Tavakoli AA; Krug D; Oppitz H; Giordano FA; Both M; Lohr F; Dunst J; Blanck O; Boda-Heggemann J
Acta Oncol; 2023 Mar; 62(3):281-289. PubMed ID: 37017543
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.
Petrelli F; Comito T; Barni S; Pancera G; Scorsetti M; Ghidini A;
Radiother Oncol; 2018 Dec; 129(3):427-434. PubMed ID: 29997034
[TBL] [Abstract][Full Text] [Related]
32. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
33. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
[No Abstract] [Full Text] [Related]
34. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience.
Vernaleone M; Bonomo P; Di Cataldo V; Saieva C; Masi L; Desideri I; Greto D; Francolini G; Becherini C; Livi L
Radiol Med; 2019 Sep; 124(9):870-876. PubMed ID: 31104277
[TBL] [Abstract][Full Text] [Related]
35. Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial.
Van den Begin R; Engels B; Boussaer M; Dhont J; Burghelea M; Depuydt T; Poels K; Collen C; Gevaert T; Verellen D; Storme G; de Mey J; De Ridder M
Radiother Oncol; 2016 Jun; 119(3):519-24. PubMed ID: 27179921
[TBL] [Abstract][Full Text] [Related]
36. Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?
Py JF; Salleron J; Vogin G; Courrech F; Teixeira P; Colnat-Coulbois S; Baumard F; Thureau S; Supiot S; Peiffert D; Oldrini G; Faivre JC
Cancer Radiother; 2023 Feb; 27(1):1-10. PubMed ID: 36641333
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
Andratschke NH; Nieder C; Heppt F; Molls M; Zimmermann F
Radiat Oncol; 2015 Mar; 10():69. PubMed ID: 25889512
[TBL] [Abstract][Full Text] [Related]
38. Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study.
Iizuka Y; Hiraoka M; Kokubo M; Sakamoto T; Karasawa K; Murofushi K; Nakamura M; Matsuo Y; Morita S; Inokuchi H; Mizowaki T
Clin Transl Radiat Oncol; 2023 Mar; 39():100591. PubMed ID: 36852258
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.
Loi M; Duijm M; Baker S; Rossi L; Grunhagen D; Verhoef C; Nuyttens J
Radiol Med; 2018 Nov; 123(11):871-878. PubMed ID: 29923086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
